Mini-antibodies show promise in reactivating p53, the "guardian of the genome" protein mutated in 50% of cancers.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Mini-antibodies reactivate the 'guardian of the genome'
20 Million people Annual cancer diagnoses
50% % Cases with p53 mutations
Mini-Antibodies Targeting P53 Reactivation Therapeutic approach